Cycn investor relations
WebJan 27, 2024 · We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold … WebApr 6, 2024 · Of the 23 institutional investors that sold Cyclerion Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Vanguard Group Inc. ($0.47M), State Street Corp ($0.32M), Renaissance Technologies LLC ($0.32M), Northern Trust Corp ($0.19M), FMR LLC ($0.13M), New …
Cycn investor relations
Did you know?
WebMar 2, 2024 · Investor Relations Cyclerion Therapeutics Inc Ordinary Shares CYCN Executive Morningstar Rating Rating as of Mar 2, 2024 Quote Chart Stock Analysis News Price vs Fair Value ... WebCYCN / Cyclerion Therapeutics Inc - Investor Relations and Targeting Tool: Recommendation Engine EXTENDED Overview Chart Owners Retail …
WebMar 31, 2024 · Short selling CYCN is an investing strategy that aims to generate trading profit from Cyclerion Therapeutics as its price is falling. CYCN shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. WebCYCN Earnings Date Earnings Per Share Estimated Reported Quarterly Earnings Surprise Amount Yearly Earnings Forecast Quarterly Earnings Forecast Change in Consensus …
WebCyclerion Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CYCN updated stock price target summary. WebCAMBRIDGE, Mass., June 10, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company on a mission to develop treatments that restore cognitive function, today announced positive topline data in its signal-seeking clinical study of CY6463, for the potential treatment of Mitochondrial ...
WebHere are some key insights as we drill into the specifics of these quality attributes. CYCN has a Quality Grade of C, ranking ahead of 48.21% of graded US stocks. CYCN's asset turnover comes in at 0.034 -- ranking 346th of 682 Pharmaceutical Products stocks. The table below shows CYCN's key quality metrics over time.
WebMar 15, 2024 · Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, … ttf albumWebCyclerion Therapeutics - CYCN - Stock Price Today - Zacks Cyclerion Therapeutics (CYCN) (Real Time Quote from BATS) $0.64 USD -0.01 (-1.55%) Updated Mar 7, 2024 03:58 PM ET Add to portfolio... phoenix bird sound effectWebCAMBRIDGE, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) today announced that the Board of Directors of the Company acting … phoenix black and white pictureWebOct 29, 2024 · Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) shareholders might be concerned after seeing the share price drop 20% in the last month. But at least the stock … phoenix black and white drawingsWebThe combined on-exchange and off-exchange short sale volume for CYCN / Cyclerion Therapeutics Inc is provided in the table below. In order to calculate an accurate short volume ratio, we gather data from a number of trading venues, but not ALL trading venues. ttf a shxWebSummary Financials Analysis Earnings Investors. . . Key Ratios Income Statement Balance Sheet Cash Flow. All. Per Share Values. Growth Rates. ... CYCN 2024. CYCN 3-Yr Avg. Biotech. 1-Yr Avg. Asset ... ttfaf dragonforceWebJan 27, 2024 · Investor Relations Cyclerion Therapeutics Inc Ordinary Shares CYCN Ownership Morningstar Rating Rating as of Jan 27, 2024 Quote Chart Stock Analysis News Price vs Fair Value ... ttfaf online